Want to see AU:CLV full AI Analyst Report?
Top Page
Clover Corporation Limited
(Sydney:CLV)
Select Model
Select Model
Rating:75Outperform
Price Target:
AU$1.00
▲(13.64% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by strong financial performance (high growth, healthy margins, and very low leverage), partially offset by a sharp decline in free cash flow growth. Technically, momentum is positive with the price above major moving averages and a positive MACD, but elevated Stochastic and a high RSI suggest the stock may be overextended. Valuation is reasonable but not compelling at a ~18 P/E with a modest ~2.1% dividend yield.
Positive Factors
Sustained revenue growth
Double-digit organic revenue growth near 18.6% demonstrates durable demand for Clover’s specialty packaging and contract manufacturing services. Sustained top-line expansion supports scale economics, underpins reinvestment in product development and customer relationships, and reduces reliance on single large contracts over the medium term.
Negative Factors
Sharp decline in free cash flow growth
A more than 60% decline in FCF growth is a durable red flag: if persistent, it reduces internal funding for capex, dividends or acquisitions and forces reliance on external financing. It may reflect higher capex, working capital stress or one-off items that impair the company’s ability to self-fund strategy.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained revenue growth
Double-digit organic revenue growth near 18.6% demonstrates durable demand for Clover’s specialty packaging and contract manufacturing services. Sustained top-line expansion supports scale economics, underpins reinvestment in product development and customer relationships, and reduces reliance on single large contracts over the medium term.
Read all positive factors
Clover Corporation Limited (CLV) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$165.33M
Dividend Yield2%
Average Volume (3M)223.73K
Price to Earnings (P/E)18.8
Beta (1Y)0.04
Revenue Growth27.60%
EPS Growth96.31%
CountryAU
Employees68
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.06
Shares Outstanding166,999,340
10 Day Avg. Volume49,116
30 Day Avg. Volume223,729
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.28
Price to Sales (P/S)1.08
P/FCF Ratio13.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.28Price Target Upside45.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.06
Revenue Forecast (FY)AU$95.30M
Clover Corporation Limited Business Overview & Revenue Model
Company Description
Clover Corporation Limited engages in the processing and worldwide sale of natural oils, reaching markets across Australia, New Zealand, Asia, Europe, and the Americas. The company's operations also encompass the creation of encapsulated products ...
How the Company Makes Money
null...
Clover Corporation Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.50M | 86.00M | 62.21M | 79.88M | 70.66M | 60.51M |
| Gross Profit | 30.77M | 26.17M | 16.86M | 23.74M | 21.66M | 18.24M |
| EBITDA | 15.20M | 12.24M | 3.98M | 10.01M | 11.66M | 10.23M |
| Net Income | 8.89M | 7.01M | 1.51M | 6.21M | 7.13M | 6.00M |
Balance Sheet | ||||||
| Total Assets | 86.98M | 86.80M | 84.39M | 86.20M | 90.77M | 78.73M |
| Cash, Cash Equivalents and Short-Term Investments | 10.27M | 8.68M | 12.26M | 9.44M | 10.11M | 9.09M |
| Total Debt | 1.26M | 2.42M | 10.39M | 11.71M | 12.08M | 14.19M |
| Total Liabilities | 13.69M | 14.57M | 17.32M | 19.05M | 27.73M | 20.32M |
| Stockholders Equity | 73.30M | 72.23M | 67.07M | 67.15M | 63.04M | 58.42M |
Cash Flow | ||||||
| Free Cash Flow | 2.96M | 6.95M | 6.13M | 5.10M | 4.51M | 6.40M |
| Operating Cash Flow | 4.47M | 8.29M | 8.45M | 6.74M | 5.93M | 8.23M |
| Investing Cash Flow | -1.51M | -1.34M | -2.97M | -2.53M | -1.43M | -1.83M |
| Financing Cash Flow | -8.07M | -10.52M | -2.66M | -4.88M | -3.49M | -6.55M |
Clover Corporation Limited Technical Analysis
Positive
0.88
Price Trends
0.88
Positive
0.91
Positive
0.83
Positive
Market Momentum
0.04
Negative
71.63
Negative
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CLV, the sentiment is Positive. The current price of 0.88 is below the 20-day moving average (MA) of 0.92, above the 50-day MA of 0.88, and above the 200-day MA of 0.83, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 71.63 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CLV.
Clover Corporation Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | AU$210.78M | 23.09 | 56.29% | ― | 174.51% | 265.77% | |
75 Outperform | AU$165.33M | 18.80 | 12.22% | 2.27% | 27.60% | 96.31% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | AU$83.15M | 21.67 | 8.70% | ― | 23.29% | ― | |
51 Neutral | AU$1.92B | 310.00 | 0.82% | 1.95% | 1.47% | -76.20% | |
45 Neutral | AU$33.25M | -0.36 | 19.78% | ― | 6.22% | 39.68% | |
39 Underperform | AU$6.66M | -0.01 | 226.76% | ― | -32.83% | 83.37% |
* Consumer Defensive Sector Average
AU:CLV
Clover Corporation Limited
1.00
0.45
81.49%
AU:NOU
Noumi Limited
0.12
-0.04
-25.00%
AU:BGA
Bega Cheese Limited
6.23
1.16
22.93%
AU:BLS
Bioxyne Limited
0.90
0.38
73.08%
AU:BUB
Bubs Australia Ltd.
0.09
-0.07
-43.13%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-4.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.